Evidence map›Paper›PMID 25467441›Full record

ArticlemBio2014

Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering.

Sumiti Vinayak, Carrie F Brooks, Anatoli Naumov, Elena S Suvorova, Michael W White, Boris Striepen

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ThemBio · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sumiti VinayakCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Carrie F BrooksCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Anatoli NaumovDepartments of Molecular Medicine & Global Health, University of South Florida, Tampa, Florida, USA.
Elena S SuvorovaDepartments of Molecular Medicine & Global Health, University of South Florida, Tampa, Florida, USA.
Michael W WhiteDepartments of Molecular Medicine & Global Health, University of South Florida, Tampa, Florida, USA.
Boris Striepenstriepen@uga.edu.
University of Georgia · USUniversity of South Florida · US

Funding

Biology of the Apicomplexan PlastidR01AI064671 · NIAID · UNIVERSITY OF GEORGIA · PI STRIEPEN, BORIS · 2006 to 2015
$3.1M
Centrosome control of Toxoplasma growthR01AI109843 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI WHITE, MICHAEL W · 2014 to 2018
$2.4M
Essential Cell Cycle Mechanisms in ToxoplasmaR01AI077662 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI WHITE, MICHAEL W · 2009 to 2013
$1.8M
Genetic dissection of parasite metabolismR01AI084415 · NIAID · UNIVERSITY OF GEORGIA · PI STRIEPEN, BORIS · 2010 to 2014
$1.7M
Genetic dissection of parasite metabolismR56AI084415 · NIAID · UNIVERSITY OF GEORGIA · PI STRIEPEN, BORIS · 2009 to 2009
$287k
NIAID NIH HHS AI064671NIAID NIH HHS AI077662NIAID NIH HHS AI084415NIAID NIH HHS R01 AI064671NIAID NIH HHS R01 AI077662NIAID NIH HHS R01 AI084415NIAID NIH HHS R01 AI109843NIAID NIH HHS R56 AI084415PHS HHS A109843Wellcome Trust
6 · The paper itself

Abstract

unlabelledApicomplexa are obligate intracellular parasites that cause important diseases in humans and animals. Manipulating the pathogen genome is the most direct way to understand the functions of specific genes in parasite development and pathogenesis. In Toxoplasma gondii, nonhomologous recombination is typically highly favored over homologous recombination, a process required for precise gene targeting. Several approaches, including the use of targeting vectors that feature large flanks to drive site-specific recombination, have been developed to overcome this problem. We have generated a new large-insert repository of T. gondii genomic DNA that is arrayed and sequenced and covers 95% of all of the parasite's genes. Clones from this fosmid library are maintained at single copy, which provides a high level of stability and enhances our ability to modify the organism dramatically. We establish a robust recombineering pipeline and show that our fosmid clones can be easily converted into gene knockout constructs in a 4-day protocol that does not require plate-based cloning but can be performed in multiwell plates. We validated this approach to understand gene function in T. gondii and produced a conditional null mutant for a nucleolar protein belonging to the NOL1/NOP2/SUN family, and we show that this gene is essential for parasite growth. We also demonstrate a powerful complementation strategy in the context of chemical mutagenesis and whole-genome sequencing. This repository is an important new resource that will accelerate both forward and reverse genetic analysis of this important pathogen. IMPORTANCE: Toxoplasma gondii is an important genetic model to understand intracellular parasitism. We show here that large-insert genomic clones are effective tools that enhance homologous recombination and allow us to engineer conditional mutants to understand gene function. We have generated, arrayed, and sequenced a fosmid library of T. gondii genomic DNA in a copy control vector that provides excellent coverage of the genome. The fosmids are maintained in a single-copy state that dramatically improves their stability and allows modification by means of a simple and highly scalable protocol. We show here that modified and unmodified fosmid clones are powerful tools for forward and reverse genetics.

Indexed as

Genome, ProtozoanGene LibraryGene TargetingGenetics, MicrobialGenetic VectorsMolecular BiologyRecombination, GeneticToxoplasma

Identifiers

PMID25467441
PMCPMC4324243
OpenAlexW2163349773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.